Necrotizing Fasciitis Market, By Type (Polymicrobial (Type I), Monomicrobial (Type II), Clostridial / Gas gangrene (Type III), and Others (e.g., Fungal necrotizing infections, atypical pathogens)), By Treatment Modality (Surgical/interventional (e.g., debridement, amputation), Antibiotic/antimicrobial therapy, Adjunctive therapies (e.g., hyperbaric oxygen, wound-care devices), and Other (Supportive care)), By Route of Administration (Parenteral and Oral), By Anatomical Location (Upper Extremities, Lower Extremities, Perineal and Genital (Fournier\\\\\\\'s Gangrene), Head and Neck, and Torso and Abdominal Wall), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Rehabilitation Centers, Diagnostic Centers, Academic and Research Institutes, and Home Healthcare), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online/e pharmacy), By Risk-Factor (Diabetes mellitus, Obesity, Immunocompromised/oncology patients, Peripheral vascular disease/chronic kidney disease, and Intravenous drug users/alcoholism), By Age Group (Infants and children (< 18 years), Adults (18–64 years), and Seniors (65+ years)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)